Search results
Results from the WOW.Com Content Network
Due to safety concerns and evidence of heart arrhythmias leading to higher death rates, the WHO suspended the hydroxychloroquine arm of the Solidarity trial in late May 2020, [14] [15] then reinstated it, [16] then withdrew it again when an interim analysis in June showed that hydroxychloroquine provided no benefit to hospitalized people ...
One of the most notable scientific papers that first popularized hydroxychloroquine as a COVID-19 treatment was retracted from its journal due to ethical and methodological issues. Retractions in ...
Hydroxychloroquine, the anti-malarial drug touted and previously taken by President Donald Trump to fight coronavirus, has fallen out of favor and public view as studies — like one halted Friday ...
The medical journal The Lancet on Thursday retracted a large study on the use of hydroxychloroquine to treat COVID-19 because of potential flaws in the research data. Thursday's retraction doesn't ...
A World Health Organization infographic that states that hydroxychloroquine does not prevent illness or death from COVID-19. Chloroquine and hydroxychloroquine are anti-malarial medications also used against some auto-immune diseases. [1] Chloroquine, along with hydroxychloroquine, was an early experimental treatment for COVID-19. [2]
Overdoses of hydroxychloroquine are extremely rare, but extremely toxic. [11] Eight people are known to have overdosed since the drug's introduction in the mid-1950s, of which three have died. [23] [24] Chloroquine has a risk of death in overdose in adults of about 20%, while hydroxychloroquine is estimated to be two or threefold less toxic. [25]
Surgisphere is an American healthcare analytics company established in 2008 by Sapan Desai.Originally a textbook marketing company, it came under scrutiny in May 2020 after it provided large datasets of COVID-19 patients that were subsequently found to be unreliable.
In July 2020, the month after the U.S. Food and Drug Administration withdrew emergency use authorization of hydroxychloroquine for COVID-19, Zelenko coauthored a retrospective study of 141 COVID-19 outpatients who were prescribed a combination of zinc, hydroxychloroquine, and azithromycin.